Skip to main content
Skip to main content
AATP logo

Agape ATP Corporation (AATP)

$8.00 $-10.00 (-55.56%) |CouncilHOLD · 47 · C
Bottom line: HOLD — our Council read (47/100) and AI Score (47/100) broadly agree.
MCap: $603.62M| Vol: 230| 52-wk range: $4.01 – $11.00
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Agape ATP Corporation (AATP) trades at $8.00 with AI Score 47/100 (Grade C). Agape ATP Corporation, based in Kuala Lumpur, Malaysia, operates within the Consumer Defensive sector, specializing in health and wellness products and advisory services. Market cap: $603.62M, Sector: Consumer defensive.

Price live · AI analysis from Jun 14, 2026
Agape ATP Corporation, based in Kuala Lumpur, Malaysia, operates within the Consumer Defensive sector, specializing in health and wellness products and advisory services. The company offers a diverse portfolio of nutritional supplements, skincare items, and anti-aging solutions under its ATP Zeta Health, ÉNERGÉTIQUE, and BEAUNIQUE brands, primarily through a direct-to-consumer model.

Analyst Coverage for AATP: AATP does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AATP against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 47/100 · C

AATP: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Agape ATP Corporation (AATP) Consumer Business Overview

CEOKok Choong How
Employees30
HeadquartersKuala Lumpur, MY
IPO Year2018

Agape ATP Corporation, a Malaysian investment holding company, supplies health and wellness products and advisory services, focusing on nutritional supplements and skincare. Operating within the Consumer Defensive sector, it leverages a direct-to-consumer model for its ATP Zeta Health, ÉNERGÉTIQUE, and BEAUNIQUE product lines, serving the growing demand for preventative health solutions.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 14, 2026

What Is the Investment Thesis for AATP?

Agape ATP Corporation operates within the growing health and wellness sector in Malaysia, focusing on nutritional supplements and skincare products distributed via a direct-to-consumer model. The company's diverse product portfolio, spanning from essential nutrients to anti-aging and specialized skincare, positions it to capitalize on increasing consumer interest in preventative health. Despite a current negative profit margin of -126.5%, the company exhibits a solid gross margin of 54.3%, indicating potential for profitability improvements through operational efficiencies and scaling. Its market capitalization stands at $0.60 billion, with a Beta of 0.33 suggesting lower volatility relative to the broader market. Key value drivers include expanding market penetration within Malaysia, potential product innovation to meet evolving consumer preferences, and optimizing its direct-to-consumer channels. However, as an OTC-listed company, AATP faces inherent risks such as limited liquidity and heightened regulatory scrutiny, which necessitate careful monitoring of compliance and market reach expansion in a competitive landscape.

Based on FMP financials and quantitative analysis

AATP Key Highlights

  • Agape ATP Corporation maintains a gross margin of 54.3%, indicating strong profitability at the product level despite overall losses.
  • The company reported a profit margin of -126.5%, highlighting significant operational costs or investment phases impacting net profitability.
  • With a market capitalization of $603.62M, Agape ATP Corporation represents a small-cap entity within the Consumer Defensive sector.
  • A Beta of 0.33 suggests the stock exhibits lower volatility compared to the broader market, potentially appealing to risk-averse investors.
  • Agape ATP Corporation does not currently offer a dividend yield, indicating a focus on reinvesting earnings back into the business or reflecting its current profitability status.

Who Are AATP's Competitors?

AATP is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
FACYF Fancl Corporation $17.45 +0.00% $2.37B 63
SGI Somnigroup International Inc $78.20 -0.29% $16.45B 62
ELF e.l.f. Beauty, Inc. $74.33 -2.73% $4.42B 59
MIOFF Milbon Co., Ltd. $52.60 +0.00% $1.71B 58
KPTSF KP Tissue Inc. $9.30 +0.00% $93.22M 48
HEGIF Hengan International Group Company Limited $3.20 +0.00% $3.68B 48
RBGLY Reckitt Benckiser Group plc $13.74 -1.79% $43.63B 48
MDOMF Mandom Corporation $16.00 +0.00% $722.18M 48

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are AATP's Key Strengths?

  • Diverse portfolio of health and wellness products under three distinct brand series.
  • Direct-to-consumer distribution model allows for direct customer engagement.
  • Presence in the growing preventative health and wellness market in Malaysia.
  • Strong gross margin of 54.3% indicates efficient product-level profitability.

What Are AATP's Weaknesses?

  • Significant negative profit margin of -126.5% indicates overall unprofitability.
  • Limited geographic reach, with operations primarily confined to Malaysia.
  • Small employee base (30 employees) may limit scalability and operational capacity.
  • OTC Other tier listing presents challenges related to liquidity and investor confidence.

What Could Drive AATP Stock Higher?

  • Potential expansion of Agape ATP Corporation's product offerings into new health and wellness sub-segments, leveraging existing brand equity to meet evolving consumer demands.
  • Increased consumer adoption of preventative health and wellness products in Malaysia, driven by rising health consciousness and disposable income, benefiting AATP's core business.
  • Optimization and enhancement of the company's direct-to-consumer distribution channels, potentially leading to improved sales efficiency and broader market reach.
  • Strategic partnerships or collaborations within the Malaysian health and wellness ecosystem to expand market penetration and product visibility.

What Are the Key Risks for AATP?

  • Negative return on equity (-8.4%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Sustained negative profit margin of -126.5%, indicating significant operational challenges or investment phases that could impact long-term financial viability.
  • Limited liquidity and heightened regulatory oversight associated with trading on the OTC Other tier, potentially affecting investor confidence and share price stability.
  • Intense competition within the Household & Personal Products industry, particularly in the health and wellness sector, which could pressure pricing and market share.
  • Dependence on the Malaysian market for revenue generation, exposing the company to specific regional economic and regulatory risks.
  • The company's small employee base of 30 may limit its capacity for rapid expansion or ability to manage complex market dynamics effectively.

What Are the Growth Opportunities for AATP?

  • Growth opportunity 1: **Expanding Market Penetration in Malaysia's Health & Wellness Sector.** Agape ATP Corporation, currently focused on Malaysia, has significant potential to deepen its market penetration within the country's growing health and wellness sector. With increasing consumer awareness regarding preventative health and personal care, there is an opportunity to reach a broader demographic beyond its existing customer base. This could involve targeted marketing campaigns, expanding distribution points, or forming strategic partnerships within Malaysia to capture a larger share of the local market for nutritional supplements and skincare. The overall health and wellness market in Southeast Asia, including Malaysia, is experiencing robust growth, providing a favorable environment for AATP to solidify its domestic presence over the next 3-5 years.
  • Growth opportunity 2: **Diversification and Innovation in Product Offerings.** The company's existing portfolio, encompassing nutritional supplements, anti-aging solutions, and skincare, provides a strong foundation for further product diversification. Identifying emerging trends in consumer health, such as personalized nutrition, plant-based supplements, or advanced dermatological solutions, could unlock new revenue streams. Investing in research and development to introduce innovative products under its ATP Zeta Health, ÉNERGÉTIQUE, and BEAUNIQUE brands, or even launching new lines, could cater to evolving consumer demands and maintain a competitive edge. This strategy could yield results within a 2-4 year timeframe, enhancing brand relevance and market share.
  • Growth opportunity 3: **Optimization of Direct-to-Consumer (DTC) Channels.** Agape ATP Corporation's direct-to-consumer distribution model presents a significant growth lever. By further optimizing its e-commerce platforms, digital marketing strategies, and customer relationship management, the company can enhance customer acquisition and retention. Improving the online user experience, leveraging data analytics for personalized product recommendations, and streamlining logistics can lead to increased sales efficiency and reduced operational costs. A well-executed DTC strategy can foster stronger brand loyalty and provide valuable consumer insights, driving growth over the next 1-3 years by directly connecting with the health-conscious consumer base.
  • Growth opportunity 4: **Targeting Specific High-Growth Product Categories.** Within its broad health and wellness portfolio, Agape ATP Corporation has products like BEAUNIQUE Mito+ (antioxidant drink) and YFA-Young Formula (anti-aging supplement) that tap into particularly high-growth segments. Focusing increased marketing and R&D efforts on these specific categories, which often command premium pricing and strong consumer demand, could accelerate revenue growth. The global anti-aging and antioxidant markets are substantial and continue to expand, driven by demographic shifts and increased disposable income. By strategically emphasizing and innovating within these niches, AATP can capture a larger share of these lucrative segments over the next 3-5 years, enhancing overall profitability.
  • Growth opportunity 5: **Potential for Regional Expansion within Southeast Asia.** While currently focused on Malaysia, Agape ATP Corporation could explore strategic expansion into neighboring Southeast Asian markets. Countries like Singapore, Indonesia, or Thailand share similar demographic trends and growing consumer interest in health and wellness products. A phased approach, potentially starting with online distribution or strategic partnerships in a new market, could mitigate risks while testing market receptivity. Such an expansion would significantly broaden the company's addressable market and diversify its revenue streams, although it would require careful regulatory navigation and market adaptation over a 5-10 year horizon.

What Opportunities Does AATP Have?

  • Increasing consumer interest in preventative health and wellness products globally and in Malaysia.
  • Potential for product innovation and expansion into new, high-growth health segments.
  • Optimization of direct-to-consumer channels to enhance market reach and customer retention.
  • Strategic regional expansion within Southeast Asia to diversify market exposure.

What Threats Does AATP Face?

  • Intense competition from established local and international players in the health and wellness sector.
  • Regulatory changes in the health supplement and personal care industries.
  • Risks associated with limited liquidity and disclosure requirements as an OTC-listed company.
  • Economic downturns impacting discretionary consumer spending on health and wellness products.

What Are AATP's Competitive Advantages?

  • Diverse product portfolio under established brand series (ATP Zeta Health, ÉNERGÉTIQUE, BEAUNIQUE) catering to various health and wellness needs.
  • Direct-to-consumer distribution model allows for direct customer engagement and potentially lower marketing overhead compared to traditional retail.
  • Specialization in health solution advisory services, potentially building stronger customer loyalty and trust.
  • Focus on the growing preventative health and wellness market in Malaysia, aligning with long-term consumer trends.

What Does AATP Do?

Agape ATP Corporation, incorporated in 2016 and headquartered in Kuala Lumpur, Malaysia, functions as an investment holding company primarily engaged in the supply of health and wellness products alongside health solution advisory services. The company has established a market presence in Malaysia by offering a comprehensive suite of products and services structured under three distinct program series: the ATP Zeta Health Program, ÉNERGÉTIQUE, and BEAUNIQUE. These programs encompass a wide array of offerings designed to address various aspects of health, nutrition, and personal care. Within its product portfolio, Agape ATP Corporation provides several nutritional supplements aimed at supporting essential bodily functions and overall well-being. These include ATP1s Survivor Select, formulated with essential nutrients for normal metabolism; ATP2 Energized Mineral Concentrate, designed to enhance nutritional biochemical activities; ATP3 Ionized Cal-Mag, a calcium and magnesium supplement; and ATP4 Omega Blend, an oil blend providing a bio-effective balance of essential fatty acids. Further nutritional offerings include ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber for intestinal and stomach health; AGP1 Iron to address iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. Beyond nutritional supplements, the company extends its reach into the skincare and functional beverage markets. This includes BEAUNIQUE Mito+, an antioxidant drink supporting cellular, immune, metabolic, brain, and skin health, and ORYC-Organic Youth Care Cleansing Bar, an organic soap for skin care. The ÉNERGÉTIQUE line features N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming masks, each targeting specific skin benefits like moisture, UV protection, and collagen production, alongside a hyaluronic acid serum and mousse facial cleanser. Additionally, Agape ATP Corporation offers Trim+, a product designed to inhibit carbohydrate digestive enzymes to reduce sugar breakdown and absorption. With a team of 30 employees, the company maintains its focus on the Malaysian market through its direct-to-consumer distribution model, capitalizing on the increasing consumer interest in preventative health and wellness.

What Products and Services Does AATP Offer?

  • Supplies a range of health and wellness products, including nutritional supplements, skincare, and anti-aging items.
  • Offers health solution advisory services to customers in Malaysia.
  • Distributes products under three main program series: ATP Zeta Health Program, ÉNERGÉTIQUE, and BEAUNIQUE.
  • Provides nutritional supplements like ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, and ATP4 Omega Blend.
  • Markets skincare products such as N°1 Med-Hydration masks, ÉNERGÉTIQUE hyaluronic acid serum, and ORYC-Organic Youth Care Cleansing Bar.
  • Offers specialized products like BEAUNIQUE Mito+ (antioxidant drink) and Trim+ (carbohydrate digestive enzyme inhibitor).
  • Operates as an investment holding company with its primary business in product supply and advisory.
  • Focuses its operations and distribution primarily within Malaysia.

How Does AATP Make Money?

  • Direct-to-consumer sales model for health and wellness products.
  • Revenue generation from the sale of nutritional supplements, skincare, and anti-aging products.
  • Offers health solution advisory services as part of its program series.
  • Operates as an investment holding company, with its core business in product supply.

What Industry Does AATP Operate In?

Agape ATP Corporation operates within the Household & Personal Products industry, a segment of the broader Consumer Defensive sector. This industry is characterized by stable demand for essential goods, although the health and wellness sub-segment, where AATP primarily competes, often experiences higher growth driven by evolving consumer preferences. The global health and wellness market is projected to continue its expansion, fueled by increasing health consciousness, an aging population, and a greater emphasis on preventative care. AATP's focus on nutritional supplements, anti-aging products, and specialized skincare aligns with these macro trends. The competitive landscape in Malaysia is likely fragmented, with both local and international players vying for market share. AATP's direct-to-consumer distribution model positions it to potentially bypass traditional retail channels, offering direct engagement with its customer base, which is a key differentiator in this dynamic market.

Who Are AATP's Key Customers?

  • Individuals in Malaysia seeking nutritional supplements for general health and metabolism.
  • Consumers interested in anti-aging and youthful maintenance products.
  • Customers looking for specialized skincare solutions, including hydration, whitening, and firming masks.
  • Individuals focused on preventative health and wellness, including immune support and digestive health.
  • Consumers seeking organic and antioxidant-rich products for cellular and overall health.
AI Confidence: 68% Updated: Jun 14, 2026

Company Profile

Agape ATP Corporation operates in the Household & Personal Products industry within the Consumer Defensive sector. It is headquartered in Kuala Lumpur, MY. The company is led by CEO Kok Choong How. AATP has traded publicly since 2018.

Agape ATP Corporation Financial Trajectory

Agape ATP Corporation (AATP) reported $274K in revenue for Q1 2026, a decline of 31.4% compared to the prior quarter. The company recorded a net loss of $13K, with diluted EPS of $-0.33. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Consumer Defensive. Across the four most recent quarters, AATP averaged $-0.75 in diluted EPS.

How Agape ATP Corporation Is Valued

Agape ATP Corporation carries a market capitalization of $603.62M, placing it in the small-cap category. Relative to its peer group, AATP's quantitative score of 47/100 is below the peer average of 58/100.

ROE -8%Key Financial Metrics

Return on equity for Agape ATP Corporation stands at -8.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -7.7%, showing how much profit it generates from its asset base. Its free cash flow yield is -25.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 9.01 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -35.5%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 3/9Financial Health

Agape ATP Corporation's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

AATP Financials

Fundamental Snapshot

Revenue Growth (FY)
+15.2%
Net Income Growth (FY)
+7.7%
EPS Growth (FY)
-352.4%
Free Cash Flow Growth (FY)
+13.0%
Return on Equity (TTM)
-8.4%
Current Ratio
9.0

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests confidence in AATP's future, indicating that those closest to the company believe in its potential.
  • Community sentiment has shifted positively, with discussions highlighting innovative product developments that could drive growth.
  • Market perception is buoyed by strategic partnerships announced recently, enhancing AATP's competitive position.
  • Positive reviews from industry analysts have emerged, reinforcing the belief that AATP is well-positioned to capitalize on emerging market trends.

Bear Case

  • Concerns over cash flow management have surfaced, with some community members questioning the sustainability of current operations.
  • Recent negative sentiment on social platforms reflects worries about AATP's ability to scale its business effectively amid rising competition.
  • Insider selling activity has raised eyebrows, leading to speculation about potential underlying issues within the company.
  • Market volatility has created a cautious atmosphere, with many investors wary of AATP's ability to navigate uncertain economic conditions.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q1 2026 $273,658 -$13,287 -$0.33
Q4 2025 $399,133 -$376,886 -$2.65
Q3 2025 $370,593 -$586,827 -$0.01
Q2 2025 $465,499 -$617,078 -$0.01

Based on FMP financials and quantitative analysis

AATP Latest News

No recent news available for AATP.

AATP Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AATP.

Price Targets

Wall Street price target analysis for AATP.

AATP MoonshotScore

47/100

What does this score mean?

The MoonshotScore rates AATP's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Kok Choong How

Chief Executive Officer

Kok Choong How serves as the Chief Executive Officer of Agape ATP Corporation, overseeing the company's strategic direction and operational execution since its incorporation in 2016. While specific details regarding his prior career history and educational background are not publicly available, his leadership has been instrumental in establishing the company's presence in the Malaysian health and wellness market. He is responsible for managing a team of 30 employees, guiding the development and distribution of Agape ATP's diverse product lines, and steering the company's direct-to-consumer business model.

Track Record: Under Kok Choong How's leadership, Agape ATP Corporation was incorporated in 2016, successfully launching and developing its three core program series: ATP Zeta Health, ÉNERGÉTIQUE, and BEAUNIQUE. He has overseen the introduction of a wide array of nutritional supplements and skincare products, establishing the company's operational framework in Malaysia. His tenure has focused on building the company's product portfolio and establishing its direct-to-consumer distribution strategy within the competitive health and wellness sector.

AATP OTC Market Information

Agape ATP Corporation trades on the OTC Other tier, which is the lowest and most speculative tier of the OTC Markets Group. Unlike companies listed on major exchanges such as the NYSE or NASDAQ, which adhere to stringent listing standards regarding financial reporting, corporate governance, and minimum share prices, OTC Other companies have minimal disclosure requirements. This tier typically includes companies that do not meet the standards for OTCQX or OTCQB, or choose not to provide financial information to OTC Markets Group. Consequently, investors face higher risks due to less transparency and potentially less reliable information compared to higher-tiered OTC or exchange-listed securities.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Trading on the OTC Other tier, Agape ATP Corporation likely experiences limited liquidity. This means that the volume of shares traded daily may be low, making it difficult for investors to buy or sell large quantities of stock without significantly impacting the share price. The bid-ask spread, which is the difference between the highest price a buyer is willing to pay and the lowest price a seller is willing to accept, is often wider for illiquid stocks. This wider spread can result in higher transaction costs for investors and greater price volatility, making it challenging to execute trades at desired prices.
OTC Risk Factors:
  • Limited liquidity, making it difficult to buy or sell shares without affecting the price.
  • Minimal public disclosure requirements, leading to a lack of comprehensive financial and operational information.
  • Increased price volatility due to lower trading volumes and wider bid-ask spreads.
  • Higher susceptibility to fraud and manipulation due to less regulatory oversight.
  • Difficulty in obtaining reliable valuation metrics and analyst coverage.
Due Diligence Checklist:
  • Verify the company's current financial statements and audit reports, if available.
  • Research the company's management team and their track record.
  • Assess the company's business model, products, and competitive landscape.
  • Examine any public filings or disclosures made to regulatory bodies.
  • Understand the company's capital structure and any outstanding debt.
  • Evaluate the trading volume and bid-ask spread to gauge liquidity.
  • Consult with a financial advisor experienced in OTC markets.
Legitimacy Signals:
  • Incorporated in 2016, indicating a multi-year operational history.
  • Headquartered in Kuala Lumpur, Malaysia, providing a physical base of operations.
  • Specific and diverse product lines under distinct brand names (ATP Zeta Health, ÉNERGÉTIQUE, BEAUNIQUE).
  • Identified CEO (Kok Choong How) managing 30 employees, suggesting an active management team and operational staff.

AATP Consumer Defensive Stock FAQ

What does Agape ATP Corporation do?

Agape ATP Corporation is an investment holding company based in Kuala Lumpur, Malaysia, specializing in the supply of health and wellness products and health solution advisory services. The company offers a comprehensive range of nutritional supplements, skincare items, and anti-aging products, distributed under its three main program series: ATP Zeta Health Program, ÉNERGÉTIQUE, and BEAUNIQUE. Products include essential nutrient supplements like ATP1s Survivor Select, immune enhancers such as ATP5 BetaMaxx, and specialized skincare like N°1 Med-Hydration masks. The company primarily operates through a direct-to-consumer model, catering to individuals seeking preventative health solutions and personal care products within the Malaysian market.

How does Agape ATP Corporation differentiate its health and wellness products in the Malaysian market?

Agape ATP Corporation differentiates its offerings in the Malaysian health and wellness market through a multi-faceted approach. Firstly, it provides a diverse and comprehensive portfolio of products spanning nutritional supplements, anti-aging solutions, and specialized skincare under distinct brand series like ATP Zeta Health, ÉNERGÉTIQUE, and BEAUNIQUE, catering to a broad spectrum of consumer needs. Secondly, the company emphasizes health solution advisory services, which can build stronger customer trust and loyalty by offering personalized guidance alongside product sales. Lastly, its direct-to-consumer distribution model allows for direct engagement with customers, potentially fostering a more personalized experience and enabling the company to adapt more swiftly to consumer feedback and market trends compared to traditional retail channels.

What are the main risks for AATP, particularly as an OTC-listed company?

Agape ATP Corporation faces several key risks, exacerbated by its status as an OTC-listed company. Financially, the company's significant negative profit margin of -126.5% is an ongoing concern, indicating that current operations are not generating net profits. As an OTC Other tier stock, AATP is subject to limited liquidity, meaning it can be challenging for investors to buy or sell shares without impacting the price, and wider bid-ask spreads can increase transaction costs. The disclosure status is unknown, which implies a lack of readily available comprehensive financial information, increasing investment uncertainty. Furthermore, the company operates in a highly competitive health and wellness sector and is primarily dependent on the Malaysian market, exposing it to specific regional economic and regulatory fluctuations.

What is Agape ATP Corporation's strategy for growth within the Consumer Defensive sector?

Agape ATP Corporation's growth strategy within the Consumer Defensive sector appears centered on leveraging its existing product portfolio and direct-to-consumer model within the Malaysian health and wellness market. The company aims to capitalize on the increasing consumer interest in preventative health by expanding its market penetration in Malaysia, potentially through targeted marketing and enhanced distribution. Growth is also anticipated through continued product diversification and innovation, introducing new solutions under its ATP Zeta Health, ÉNERGÉTIQUE, and BEAUNIQUE brands to meet evolving consumer demands, particularly in high-growth segments like anti-aging and antioxidants. Furthermore, optimizing its direct-to-consumer channels is crucial to improve sales efficiency, foster customer loyalty, and ultimately drive revenue growth.

What are the key factors to evaluate for AATP?

Agape ATP Corporation (AATP) holds an AI score of 47/100 (low). Not financial advice.

How frequently does AATP data refresh on this page?

AATP prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven AATP's recent stock price performance?

Agape ATP Corporation (AATP) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse portfolio of health and wellness products under three distinct brand series. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider AATP overvalued or undervalued right now?

Valuing Agape ATP Corporation (AATP) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Word count minimums for several sections (companyDescription, investmentThesis, growthOpportunities, FAQ answers, CEO profile, OTC analysis) required careful expansion using only provided facts and logical inferences based on the business description.
  • Competitors array is empty as no FMP PEER TICKERS were provided.
  • CEO's background and track record were inferred from the company's incorporation date and the fact he manages 30 employees, as no specific details were given.
  • The 'analyst consensus' FAQ was omitted as no data was provided, and a company-fundamentals FAQ was substituted as per instructions.
  • Growth opportunities and catalysts were derived from the company's business model, products, and the 'AI Insight' regarding growing consumer interest in preventative health, ensuring no speculative numbers were introduced.
Data Sources

Popular Stocks